BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11351331)

  • 1. Disrupting the transforming activity of shrimp ras(Q(61)K) by deleting the CAAX box at the C-terminus.
    Huang CF; Chen CH; Chuang NN
    J Exp Zool; 2001 Jun; 289(7):441-8. PubMed ID: 11351331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupting the geranylgeranylation at the C-termini of the shrimp Ras by depriving guanine nucleotide binding at the N-terminal.
    Huang CF; Chuang NN
    J Exp Zool; 2000 Apr; 286(5):441-9. PubMed ID: 10684567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GTPase stimulation in shrimp Ras(Q(61)K) with geranylgeranyl pyrophosphate but not mammalian GAP.
    Chang KC; Chuang NN
    J Exp Zool; 2001 Nov; 290(6):642-51. PubMed ID: 11748613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesylation and proteolysis are sequential, but distinct steps in the CaaX box modification pathway.
    Farh L; Mitchell DA; Deschenes RJ
    Arch Biochem Biophys; 1995 Apr; 318(1):113-21. PubMed ID: 7726551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prenyl pyrophosphates on the binding of S-Ras proteins with KSR.
    Chen CH; Fan JH; Chuang NN
    J Exp Zool; 2002 Nov; 293(6):551-60. PubMed ID: 12410604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trap RACK1 with Ras to mobilize Src signaling at syndecan-2/p120-GAP upon transformation with oncogenic ras.
    Huang JW; Chen CL; Chuang NN
    Biochem Biophys Res Commun; 2005 May; 330(4):1087-94. PubMed ID: 15823555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitated geranylgeranylation of shrimp ras-encoded p25 fusion protein by the binding with guanosine diphosphate.
    Huang CF; Chuang NN
    J Exp Zool; 1999 May; 283(6):510-21. PubMed ID: 10194860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of shrimp ras protein with mammalian caveolin-1.
    Chen CH; Wang HC; Chuang NN
    J Exp Zool; 2000 Nov; 287(6):432-9. PubMed ID: 11074455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
    Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
    Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.
    Carboni JM; Yan N; Cox AD; Bustelo X; Graham SM; Lynch MJ; Weinmann R; Seizinger BR; Der CJ; Barbacid M
    Oncogene; 1995 May; 10(10):1905-13. PubMed ID: 7761092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors.
    Fiordalisi JJ; Johnson RL; Weinbaum CA; Sakabe K; Chen Z; Casey PJ; Cox AD
    J Biol Chem; 2003 Oct; 278(43):41718-27. PubMed ID: 12882980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody.
    Baron R; Fourcade E; Lajoie-Mazenc I; Allal C; Couderc B; Barbaras R; Favre G; Faye JC; Pradines A
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11626-31. PubMed ID: 11027361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimerize RACK1 upon transformation with oncogenic ras.
    Chu LY; Chen YH; Chuang NN
    Biochem Biophys Res Commun; 2005 May; 330(2):474-82. PubMed ID: 15796907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion.
    Sun J; Qian Y; Hamilton AD; Sebti SM
    Cancer Res; 1995 Oct; 55(19):4243-7. PubMed ID: 7671229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
    Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
    Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymology and biology of CaaX protein prenylation.
    Fu HW; Casey PJ
    Recent Prog Horm Res; 1999; 54():315-42; discussion 342-3. PubMed ID: 10548882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-Ras promotes tumor growth of cervical epithelial cells.
    Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C
    Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum growth factors up-regulate H-ras, K-ras, and N-ras proto-oncogenes in fibroblasts.
    Quincoces AF; León J
    Cell Growth Differ; 1995 Mar; 6(3):271-9. PubMed ID: 7794795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I.
    Vasudevan A; Qian Y; Vogt A; Blaskovich MA; Ohkanda J; Sebti SM; Hamilton AD
    J Med Chem; 1999 Apr; 42(8):1333-40. PubMed ID: 10212118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.